# Turning Point Brands, Inc.: financial statements, quarterly

TPB · NYSE · CIK 1290677 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tpb.md) · [Financials](/companies/tpb/financials.md) · [Filings](/companies/tpb/filings.md) · [Insiders](/companies/tpb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tpb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [83.7](/filings/0001437749-25-006480.md) | [83.1](/filings/0001437749-25-006480.md) | [83.1](/filings/0001437749-25-015189.md) | [93.2](/filings/0001437749-25-025965.md) | [90.7](/filings/0001437749-25-033374.md) | [93.7](/filings/0001437749-25-006480.md) | [106](/filings/0001437749-26-015910.md) | [117](/filings/0001437749-26-025664.md) | [119](/filings/0001437749-25-033374.md) | [121 d](/filings/0001437749-26-006405.md) | [124](/filings/0001437749-26-015910.md) | [143](/filings/0001437749-26-025664.md) |
| Cost of revenue | $m | [50.1](/filings/0001140361-24-045671.md) | [(13.4) d](/filings/0001437749-26-006405.md) | [34.7](/filings/0001437749-25-015189.md) | [42.8](/filings/0001437749-25-025965.md) | [40.3](/filings/0001437749-25-033374.md) | [41.2 d](/filings/0001437749-26-006405.md) | [46.8](/filings/0001437749-26-015910.md) | [50.0](/filings/0001437749-26-025664.md) | [48.6](/filings/0001437749-25-033374.md) | [53.4 d](/filings/0001437749-26-006405.md) | [56.0](/filings/0001437749-26-015910.md) | [49.3](/filings/0001437749-26-025664.md) |
| Gross profit | $m | [47.3](/filings/0001437749-25-006480.md) | [47.4](/filings/0001437749-25-006480.md) | [48.4](/filings/0001437749-25-015189.md) | [50.4](/filings/0001437749-25-025965.md) | [50.4](/filings/0001437749-25-033374.md) | [52.4](/filings/0001437749-25-006480.md) | [59.6](/filings/0001437749-26-015910.md) | [66.6](/filings/0001437749-26-025664.md) | [70.4](/filings/0001437749-25-033374.md) | [67.7 d](/filings/0001437749-26-006405.md) | [68.3](/filings/0001437749-26-015910.md) | [93.7](/filings/0001437749-26-025664.md) |
| Selling, general and administrative | $m | [31.4](/filings/0001140361-24-045671.md) | [10.2 d](/filings/0001437749-26-006405.md) | [29.1](/filings/0001437749-25-015189.md) | [29.2](/filings/0001437749-25-025965.md) | [29.6](/filings/0001437749-25-033374.md) | [34.5 d](/filings/0001437749-26-006405.md) | [36.4](/filings/0001437749-26-015910.md) | [40.3](/filings/0001437749-26-025664.md) | [44.5](/filings/0001437749-25-033374.md) | [47.7 d](/filings/0001437749-26-006405.md) | [55.8](/filings/0001437749-26-015910.md) | [77.0](/filings/0001437749-26-025664.md) |
| Operating income | $m | [20.7](/filings/0001437749-25-006480.md) | [24.6](/filings/0001437749-25-006480.md) | [19.3](/filings/0001437749-25-015189.md) | [22.9](/filings/0001437749-25-025965.md) | [20.8](/filings/0001437749-25-033374.md) | [17.9](/filings/0001437749-25-006480.md) | [23.2](/filings/0001437749-26-015910.md) | [26.3](/filings/0001437749-26-025664.md) | [25.9](/filings/0001437749-25-033374.md) | [19.9 d](/filings/0001437749-26-006405.md) | [12.5](/filings/0001437749-26-015910.md) | [16.7](/filings/0001437749-26-025664.md) |
| Interest expense | $m | [5.2](/filings/0001140361-24-045671.md) | [5.1 d](/filings/0001437749-26-006405.md) | [5.3](/filings/0001437749-25-015189.md) | [5.4](/filings/0001437749-25-025965.md) | [4.6](/filings/0001437749-25-033374.md) | [3.3 d](/filings/0001437749-26-006405.md) | [5.7](/filings/0001437749-26-015910.md) | [6.6](/filings/0001437749-26-025664.md) | [7.0](/filings/0001437749-25-033374.md) | [6.1 d](/filings/0001437749-26-006405.md) | [7.2](/filings/0001437749-26-015910.md) | [7.8](/filings/0001437749-26-025664.md) |
| Income tax | $m | [3.8](/filings/0001140361-24-045671.md) | [14.4 d](/filings/0001437749-26-006405.md) | [3.7](/filings/0001437749-25-015189.md) | [4.4](/filings/0001437749-25-025965.md) | [4.7](/filings/0001437749-25-033374.md) | [4.1 d](/filings/0001437749-26-006405.md) | [2.0](/filings/0001437749-26-015910.md) | [4.2](/filings/0001437749-26-025664.md) | [6.5](/filings/0001437749-25-033374.md) | [2.2 d](/filings/0001437749-26-006405.md) | [(2.8)](/filings/0001437749-26-015910.md) | [3.7](/filings/0001437749-26-025664.md) |
| Net income | $m | [10.8](/filings/0001437749-25-006480.md) | [10.1](/filings/0001437749-25-006480.md) | [12.0](/filings/0001437749-25-015189.md) | [13.0](/filings/0001437749-25-025965.md) | [12.4](/filings/0001437749-25-033374.md) | [2.4](/filings/0001437749-25-006480.md) | [14.4](/filings/0001437749-26-015910.md) | [14.5](/filings/0001437749-26-025664.md) | [21.1](/filings/0001437749-25-033374.md) | [8.2 d](/filings/0001437749-26-006405.md) | [11.7](/filings/0001437749-26-015910.md) | [3.6](/filings/0001437749-26-025664.md) |
| Diluted EPS | $ per share | [0.58](/filings/0001437749-25-006480.md) | [0.53](/filings/0001437749-25-006480.md) | [0.63](/filings/0001437749-25-015189.md) | [0.68](/filings/0001437749-25-025965.md) | [0.68](/filings/0001437749-25-033374.md) | [0.13](/filings/0001437749-25-006480.md) | [0.79](/filings/0001437749-25-015189.md) | [0.79](/filings/0001437749-25-025965.md) | [1.13](/filings/0001437749-25-033374.md) | not reported | not reported | not reported |
| Basic EPS | $ per share | [0.62](/filings/0001437749-25-006480.md) | [0.57](/filings/0001437749-25-006480.md) | [0.68](/filings/0001437749-25-015189.md) | [0.74](/filings/0001437749-25-025965.md) | [0.70](/filings/0001437749-25-033374.md) | [0.14](/filings/0001437749-25-006480.md) | [0.81](/filings/0001437749-26-015910.md) | [0.81](/filings/0001437749-26-025664.md) | [1.16](/filings/0001437749-25-033374.md) | not reported | [0.61](/filings/0001437749-26-015910.md) | [0.18](/filings/0001437749-26-025664.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [96.1](/filings/0001140361-24-045671.md) | [118](/filings/0001437749-26-006405.md) | [131](/filings/0001437749-25-015189.md) | [142](/filings/0001437749-25-025965.md) | [33.6](/filings/0001437749-25-033374.md) | [48.9](/filings/0001437749-26-025664.md) | [99.6](/filings/0001437749-26-015910.md) | [110](/filings/0001437749-26-025664.md) | [201](/filings/0001437749-25-033374.md) | [223](/filings/0001437749-26-025664.md) | [192](/filings/0001437749-26-015910.md) | [268](/filings/0001437749-26-025664.md) |
| Current assets | $m | [247](/filings/0001140361-23-052085.md) | [268](/filings/0001437749-25-006480.md) | [279](/filings/0001140361-24-024041.md) | [290](/filings/0001140361-24-035344.md) | [185](/filings/0001140361-24-045671.md) | [198](/filings/0001437749-26-006405.md) | [259](/filings/0001437749-25-015189.md) | [285](/filings/0001437749-25-025965.md) | [396](/filings/0001437749-25-033374.md) | [417](/filings/0001437749-26-025664.md) | [418](/filings/0001437749-26-015910.md) | [500](/filings/0001437749-26-025664.md) |
| Total assets | $m | [554](/filings/0001140361-23-052085.md) | [569](/filings/0001437749-25-006480.md) | [586](/filings/0001140361-24-024041.md) | [592](/filings/0001140361-24-035344.md) | [488](/filings/0001140361-24-045671.md) | [493](/filings/0001437749-26-006405.md) | [565](/filings/0001437749-25-015189.md) | [596](/filings/0001437749-25-025965.md) | [743](/filings/0001437749-25-033374.md) | [764](/filings/0001437749-26-025664.md) | [772](/filings/0001437749-26-015910.md) | [855](/filings/0001437749-26-025664.md) |
| Current liabilities | $m | [86.7](/filings/0001140361-23-052085.md) | [100](/filings/0001437749-25-006480.md) | [109](/filings/0001140361-24-024041.md) | [161](/filings/0001140361-24-035344.md) | [43.9](/filings/0001140361-24-045671.md) | [44.8](/filings/0001437749-26-006405.md) | [58.6](/filings/0001437749-25-015189.md) | [67.5](/filings/0001437749-25-025965.md) | [71.3](/filings/0001437749-25-033374.md) | [75.0](/filings/0001437749-26-025664.md) | [71.3](/filings/0001437749-26-015910.md) | [88.2](/filings/0001437749-26-025664.md) |
| Total liabilities | $m | [414](/filings/0001140361-23-052085.md) | [417](/filings/0001437749-25-006480.md) | [425](/filings/0001140361-24-024041.md) | [418](/filings/0001140361-24-035344.md) | [301](/filings/0001140361-24-045671.md) | [303](/filings/0001437749-26-006405.md) | [361](/filings/0001437749-25-015189.md) | [371](/filings/0001437749-25-025965.md) | [385](/filings/0001437749-25-033374.md) | [392](/filings/0001437749-26-025664.md) | [387](/filings/0001437749-26-015910.md) | [401](/filings/0001437749-26-025664.md) |
| Long-term debt | $m | [317](/filings/0001140361-23-052085.md) | [307](/filings/0001437749-25-006480.md) | [306](/filings/0001140361-24-024041.md) | [248](/filings/0001140361-24-035344.md) | [248](/filings/0001140361-24-045671.md) | [249](/filings/0001437749-26-006405.md) | [293](/filings/0001437749-25-015189.md) | [293](/filings/0001437749-25-025965.md) | [293](/filings/0001437749-25-033374.md) | [294](/filings/0001437749-26-025664.md) | [294](/filings/0001437749-26-015910.md) | [294](/filings/0001437749-26-025664.md) |
| Current portion of debt | $m | [48.2](/filings/0001140361-23-052085.md) | [58.3](/filings/0001437749-25-006480.md) | [59.4](/filings/0001140361-24-024041.md) | [118](/filings/0001140361-24-035344.md) | [0.0](/filings/0001140361-24-045671.md) | [0.0](/filings/0001437749-25-006480.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [139](/filings/0001140361-23-052085.md) | [151](/filings/0001140361-24-045671.md) | [160](/filings/0001140361-24-024041.md) | [173](/filings/0001140361-24-035344.md) | [186](/filings/0001140361-24-045671.md) | [190](/filings/0001437749-26-025664.md) | [203](/filings/0001437749-26-025664.md) | [225](/filings/0001437749-26-025664.md) | [358](/filings/0001437749-25-033374.md) | [372](/filings/0001437749-26-025664.md) | [385](/filings/0001437749-26-025664.md) | [454](/filings/0001437749-26-025664.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [12.5 d](/filings/0001140361-24-045671.md) | [26.9 d](/filings/0001437749-26-006405.md) | [22.6](/filings/0001437749-25-015189.md) | [13.4 d](/filings/0001437749-25-025965.md) | [13.2 d](/filings/0001437749-25-033374.md) | [17.7 d](/filings/0001437749-26-006405.md) | [17.4](/filings/0001437749-26-015910.md) | [11.8 d](/filings/0001437749-26-025664.md) | [3.3 d](/filings/0001437749-25-033374.md) | [24.9 d](/filings/0001437749-26-006405.md) | [(22.3)](/filings/0001437749-26-015910.md) | [26.3 d](/filings/0001437749-26-025664.md) |
| Capital expenditure | $m | [1.2 d](/filings/0001140361-24-045671.md) | [1.5 d](/filings/0001437749-26-006405.md) | [0.4](/filings/0001437749-25-015189.md) | [2.5 d](/filings/0001437749-25-025965.md) | [0.7 d](/filings/0001437749-25-033374.md) | [1.1 d](/filings/0001437749-26-006405.md) | [2.2](/filings/0001437749-26-015910.md) | [4.0 d](/filings/0001437749-26-025664.md) | [4.0 d](/filings/0001437749-25-033374.md) | [3.3 d](/filings/0001437749-26-006405.md) | [5.1](/filings/0001437749-26-015910.md) | [0.1 d](/filings/0001437749-26-025664.md) |
| Dividends paid | $m | [1.1 d](/filings/0001140361-24-045671.md) | [1.1 d](/filings/0001437749-26-006405.md) | [1.1](/filings/0001437749-25-015189.md) | [1.3 d](/filings/0001437749-25-025965.md) | [1.2 d](/filings/0001437749-25-033374.md) | [1.3 d](/filings/0001437749-26-006405.md) | [1.4](/filings/0001437749-26-015910.md) | [1.3 d](/filings/0001437749-26-025664.md) | [1.4 d](/filings/0001437749-25-033374.md) | [1.4 d](/filings/0001437749-26-006405.md) | [1.7](/filings/0001437749-26-015910.md) | [1.6 d](/filings/0001437749-26-025664.md) |
| Share repurchases | $m | [0.0 d](/filings/0001140361-24-045671.md) | [0.0 d](/filings/0001437749-26-006405.md) | [2.1](/filings/0001437749-25-015189.md) | [1.0 d](/filings/0001437749-25-025965.md) | [1.1 d](/filings/0001437749-25-033374.md) | [0.9 d](/filings/0001437749-26-006405.md) | [0.0](/filings/0001437749-25-015189.md) | [0.0 d](/filings/0001437749-25-025965.md) | [0.0 d](/filings/0001437749-25-033374.md) | [0.0 d](/filings/0001437749-26-006405.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [21.1](/filings/0001140361-23-052085.md) | [20.7](/filings/0001140361-24-024041.md) | [20.4](/filings/0001140361-24-035344.md) | [20.1](/filings/0001140361-24-045671.md) | [20.2](/filings/0001437749-25-015189.md) | [20.2](/filings/0001437749-25-025965.md) | [18.4](/filings/0001437749-25-033374.md) | [18.2](/filings/0001437749-26-015910.md) | [18.3](/filings/0001437749-26-025664.md) | [18.7](/filings/0001437749-25-033374.md) | [19.5](/filings/0001437749-26-015910.md) | [20.2](/filings/0001437749-26-025664.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 20,048,922 at 2026-07-28, from the cover of the [10-Q filed 2026-08-04](/filings/0001437749-26-025664.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.